Jun. 18, 2022
compound 4e
inhaled p38α/β MAPK inhibitor effective in the rat LPS-induced lung inflamm. model SBDD and focus on slow dissociation kinetics J. Med. Chem., May 11, 2022 Chiesi Farmaceutici, Parma, IT
inhaled p38α/β MAPK inhibitor effective in the rat LPS-induced lung inflamm. model SBDD and focus on slow dissociation kinetics J. Med. Chem., May 11, 2022 Chiesi Farmaceutici, Parma, IT